Prospects for a genomic approach to the treatment of alcoholism
- PMID: 18250250
- DOI: 10.1001/archgenpsychiatry.2007.32
Prospects for a genomic approach to the treatment of alcoholism
Comment on
-
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.Arch Gen Psychiatry. 2008 Feb;65(2):135-44. doi: 10.1001/archpsyc.65.2.135. Arch Gen Psychiatry. 2008. PMID: 18250251 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical